Zimmer Biomet Holdings (ZBH) FCF Margin (2009 - 2026)
Zimmer Biomet Holdings' quarterly FCF Margin came in at 15.48% in Q1 2026, down 223.0% year-on-year from 12.59% in Q1 2025, and down 21.5% quarter-over-quarter from 19.73% in Q4 2025.
Zimmer Biomet Holdings has reported FCF Margin for 18 years, with the latest figure at 15.48% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 223.0% year-over-year to 15.48%; the trailing twelve-month figure through Mar 2026 stood at 17.33% (down 164.0% YoY), and the FY2025 full-year result was 17.89%, up 102.0% from the prior year.
- FCF Margin for Q1 2026 stood at 15.48%, down from 19.73% in the prior quarter.
- The five-year high for FCF Margin was 27.09% in Q4 2023, with the low at 9.15% in Q1 2024.
- Average FCF Margin over 5 years is 17.13%, with a median of 16.79% recorded in 2022.
- Peak annual rise in FCF Margin reached 1719 bps in 2023, while the deepest fall reached 973 bps in 2023.
- Tracing ZBH's FCF Margin over 5 years: stood at 9.91% in 2022, then jumped by 173 bps to 27.09% in 2023, then slipped by 17 bps to 22.48% in 2024, then retreated by 12 bps to 19.73% in 2025, then decreased by 22 bps to 15.48% in 2026.
- The last three FCF Margin figures came in at 15.48% (Q1 2026), 19.73% (Q4 2025), and 18.17% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 15.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.48% |
| Dec 31, 2025 | 19.73% |
| Sep 30, 2025 | 18.17% |
| Jun 30, 2025 | 15.79% |
| Mar 31, 2025 | 17.72% |
| Dec 31, 2024 | 22.48% |
| Sep 30, 2024 | 19.25% |
| Jun 30, 2024 | 16.31% |
| Mar 31, 2024 | 9.15% |
| Dec 31, 2023 | 27.09% |
| Sep 30, 2023 | 14.44% |
| Jun 30, 2023 | 13.40% |
| Mar 31, 2023 | 14.25% |
| Dec 31, 2022 | 9.91% |
| Sep 30, 2022 | 24.17% |
| Jun 30, 2022 | 17.10% |
| Mar 31, 2022 | 16.79% |
| Dec 31, 2021 | 16.23% |
| Sep 30, 2021 | 22.56% |
| Jun 30, 2021 | 22.37% |
| Mar 31, 2021 | 12.35% |
| Dec 31, 2020 | 13.14% |
| Sep 30, 2020 | 18.18% |
| Jun 30, 2020 | -5.86% |
| Mar 31, 2020 | 23.02% |
| Dec 31, 2019 | 17.48% |
| Sep 30, 2019 | 27.44% |
| Jun 30, 2019 | 12.17% |
| Mar 31, 2019 | 12.44% |
| Dec 31, 2018 | 16.03% |
| Sep 30, 2018 | 23.01% |
| Jun 30, 2018 | 18.25% |
| Mar 31, 2018 | 22.99% |
| Dec 31, 2017 | 17.25% |
| Sep 30, 2017 | 23.58% |
| Jun 30, 2017 | 21.02% |
| Mar 31, 2017 | 11.78% |
| Dec 31, 2016 | 28.44% |
| Sep 30, 2016 | 16.16% |
| Jun 30, 2016 | 17.24% |
| Mar 31, 2016 | 12.88% |
| Dec 31, 2015 | 21.38% |
| Sep 30, 2015 | 2.54% |
| Jun 30, 2015 | 14.29% |
| Mar 31, 2015 | 5.03% |
| Dec 31, 2014 | 25.57% |
| Sep 30, 2014 | 20.20% |
| Jun 30, 2014 | 18.78% |
| Mar 31, 2014 | 13.55% |
| Dec 31, 2013 | 22.36% |
| Sep 30, 2013 | 23.81% |
| Jun 30, 2013 | 14.31% |
| Mar 31, 2013 | 14.28% |
| Dec 31, 2012 | 27.51% |
| Sep 30, 2012 | 31.00% |
| Jun 30, 2012 | 18.37% |
| Mar 31, 2012 | 16.47% |
| Dec 31, 2011 | 29.74% |
| Sep 30, 2011 | 30.71% |
| Jun 30, 2011 | 20.58% |
| Mar 31, 2011 | 14.80% |
| Dec 31, 2010 | 26.65% |
| Sep 30, 2010 | 31.75% |
| Jun 30, 2010 | 24.35% |
| Mar 31, 2010 | 23.33% |
| Dec 31, 2009 | 32.26% |
| Sep 30, 2009 | 33.85% |
| Jun 30, 2009 | 16.80% |
| Mar 31, 2009 | 15.48% |